| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -66,136 | -58,062 | -313,918 | -125,775 |
| Intangible asset impairment charges | NaN | NaN | NaN | 53,000 |
| Share-based compensation | 2,568 | 3,006 | 3,496 | 2,668 |
| Depreciation and amortization | 307 | 410 | 3,508 | 5,646 |
| Amortization of intangible assets | 0 | 0 | 23,514 | 47,028 |
| Amortization of debt discount and issuance costs | 3,046 | 2,891 | 2,695 | 1,992 |
| Gain on bargain purchase | NaN | 0 | 0 | NaN |
| Loss on extinguishment of debt | NaN | 0 | -1,655 | NaN |
| Deferred tax liability | 668 | -4,165 | 0 | 403 |
| Non-cash lease expense | 517 | 517 | 749 | 1,710 |
| Other non-cash items | 425 | 0 | 21 | 325 |
| Accrued interest payable in kind | 13,347 | 12,005 | 13,514 | 13,808 |
| Indefinite and long-lived asset impairment charges | 0 | 0 | 259,961 | NaN |
| Accounts receivable | -77 | 71 | -141 | -4,309 |
| Operating lease impairment charges | NaN | NaN | NaN | 798 |
| Commissions receivable | -72,789 | -38,849 | -32,604 | -56,994 |
| Prepaid expenses and other assets | -2,749 | -4,227 | -10,292 | -8,035 |
| Accounts payable | 1,543 | -4,928 | -8,035 | 5,296 |
| Accrued liabilities | -10,075 | -26,266 | -54 | -60,329 |
| Deferred revenue | -1,699 | -3,702 | -4,246 | -20,280 |
| Commissions payable | -11,312 | -13,658 | -3,559 | -38,732 |
| Operating lease liabilities | -447 | 980 | -1,172 | -2,702 |
| Other liabilities | -531 | 8,893 | 23 | -3,766 |
| Net cash provided by (used in) operating activities | 6,986 | -39,074 | -32,651 | -50,222 |
| Acquisition of business, net | NaN | 0 | 0 | NaN |
| Purchases of property, equipment and software | 0 | 0 | 2,371 | 5,877 |
| Net cash provided by (used in) investing activities | 0 | 0 | -2,371 | -5,877 |
| Proceeds from borrowings | NaN | 40,000 | 39,499 | 58,500 |
| Repayment of borrowings | 0 | 0 | 0 | 2,375 |
| Payment of debt discount and issuance costs | NaN | 0 | 7,977 | 431 |
| Repurchase of shares to satisfy employee tax withholding obligations | 25 | 91 | 102 | 5,028 |
| Proceeds from stock option exercises | 0 | 0 | 0 | 1 |
| Payment of preferred stock dividends | NaN | 0 | NaN | NaN |
| Net cash provided by (used in) financing activities | -25 | 39,909 | 31,420 | 50,667 |
| Effect of exchange rate changes on cash and cash equivalents | 14 | -7 | 88 | 101 |
| Increase (decrease) in cash and cash equivalents | 6,975 | 828 | -3,514 | -5,331 |
| Cash and cash equivalents at beginning of period | 32,904 | 32,076 | 40,921 | NaN |
| Cash and cash equivalents at end of period | 39,879 | 32,904 | 32,076 | NaN |
GoHealth, Inc. (GOCO)
GoHealth, Inc. (GOCO)